🟢 Aquestive Therapeutics Inc is trading 5.2% up today on continued momentum and broader market gains

Aquestive Therapeutics Inc is trading 5.2% up at $4.66 on continued recent momentum and a positive broader market backdrop.

• No fresh company-specific news, earnings, FDA updates, or analyst actions dated June 18, 2026, have surfaced to explain the move.
• The price action appears aligned with the stock’s existing multi-day uptrend and gains across major U.S. indices rather than a new, identifiable catalyst.